Biotech and pharmaceutical companies
Pfizer and Johnson & Johnson, both based in the United States, are among the world’s largest biotechnology and pharmaceutical companies based on their net incomes of approximately 15 billion U.S. dollars and 12 billion U.S. dollars, respectively, as of 2018. Pfizer generated 53 billion U.S. dollars of revenue in this year. Johnson & Johnson accumulated a market capitalization of 354 billion U.S. dollars as of 2018. Roche, a Switzerland-based company, is considered one of the leaders in biotech drugs, generating over 34 billion U.S. dollars in 2017 and is expected to reach some 42 billion U.S. dollars in biotech prescription drug revenue in 2024.
Lyrica is one of Pfizer’s most successful products. It is an anticonvulsant for neuropathic pain and is also used as therapy for partial seizures. In the EU and in Russia, Lyrica has also been approved to treat general anxiety disorder. In 2017, this prescription medication generated some five billion U.S. dollars in revenue. The United States and France boast the largest number of biotechnology companies in the world by a significant margin. As of 2014, there were 934 dedicated biotechnology companies in the United States and 1,284 companies in France.